Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ).
Lee’s Pharmaceutical Holdings Limited has announced its upcoming Annual General Meeting (AGM) scheduled for May 22, 2025, where shareholders will consider several key resolutions. These include the approval of audited financial statements, declaration of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, the company seeks authorization to repurchase up to 10% of its issued shares, reflecting a strategic move to manage its share capital and potentially enhance shareholder value.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products, primarily serving the healthcare market.
YTD Price Performance: -7.75%
Average Trading Volume: 304,493
Technical Sentiment Signal: Buy
Current Market Cap: HK$771.4M
For detailed information about 0950 stock, go to TipRanks’ Stock Analysis page.